drugset / Trial / NCT00741442
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether RDEA806 is effective in the treatment of hyperuricemia in gout patients.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-04
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RDEA806 | Unknown | 400 mg | — |
Indications
No indication recorded.